QR Code

Inhaled clofazimine adminsitration increases antimycobacterial effect compared to oral administration in a hollow-fibre system

AIM: To compare the antimycobacterial effect of inhaled versus oral clofazimine administration with an azithromycin-ethambutol backbone. BACKGROUND: Mycobacterium avium complex causes non-tuberculous pulmonary disease. Clofazimine can replace rifampicine in combination with an azithromycin-ethambuto...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jelmer Raaijmakers, Rob E. Aarnoutse, Lindsey Te Brake, Ralf Stemkens, Heiman F.l. Wertheim, Wouter Hoefsloot, Jakko Van Ingen
Format: Artigo
Langue:Inglês
Publié: Elsevier 2024-12-01
Collection:Journal of Global Antimicrobial Resistance
Sujets:
Accès en ligne:http://www.sciencedirect.com/science/article/pii/S221371652400362X
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!